Abbott announces world's first implant of dual-chamber leadless pacemaker in pivotal trial

Abbott park, ill., feb. 7, 2022 /prnewswire/ -- abbott (nyse: abt) today announced the world's first patient implants of a dual-chamber leadless pacemaker system as part of its aveir dr i2i™ pivotal clinical study.
ABT Ratings Summary
ABT Quant Ranking